http://www.unboundmedicine.com/medline/ebm/research/daptomycinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19891570/full_citation/Early_experience_with_high_dosage_daptomycin_for_prosthetic_infections_De Rosa FG, Mollaretti O, Cometto C, et al. 
Early experience with high-dosage daptomycin for prosthetic infections. [Comment, Letter]
Clin Infect Dis 2009 Dec 1; 49(11):1772-3.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19887592/full_citation/Multidrug_Resistant_Enterococcus_faecium_Endocarditis_Treated_with_Combination_Tigecycline_and_High_Dose_Daptomycin__December__Schutt AC, Bohm NM 
Multidrug-Resistant Enterococcus faecium Endocarditis Treated with Combination Tigecycline and High-Dose Daptomycin (December). [JOURNAL ARTICLE]
Ann Pharmacother 2009 Nov 3.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19876662/full_citation/Detection_of_new_mutations_conferring_resistance_to_linezolid_in_glycopeptide_intermediate_susceptibility_Staphylococcus_hominis_subspecies_hominis_circulating_in_an_intensive_care_unit_Sorlozano A, Gutierrez J, Martinez T, et al. 
Detection of new mutations conferring resistance to linezolid in glycopeptide-intermediate susceptibility Staphylococcus hominis subspecies hominis circulating in an intensive care unit. [JOURNAL ARTICLE]
Eur J Clin Microbiol Infect Dis 2009 Oct 30.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19875242/full_citation/[In_vitro_activity_of_daptomycin_against_strains_isolated_from_diabetic_foot_ulcers_]Sotto A, Laouini D, Bouziges N, et al. 
[In vitro activity of daptomycin against strains isolated from diabetic foot ulcers.] [JOURNAL ARTICLE]
Pathol Biol (Paris) 2009 Oct 27.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19857129/full_citation/Daptomycin_Activity_Tested_Against_Linezolid_Nonsusceptible_Gram_Positive_Clinical_Isolates_Mendes RE, Jones RN, Deshpande LM, et al. 
Daptomycin Activity Tested Against Linezolid-Nonsusceptible Gram-Positive Clinical Isolates. [JOURNAL ARTICLE]
Microb Drug Resist 2009 Dec; 15(4):245-249.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19849702/full_citation/Diminished_in_vitro_antibacterial_activity_of_oxacillin_against_clinical_isolates_of_borderline_oxacillin_resistant_Staphylococcus_aureus_Croes S, Beisser PS, Terporten PH, et al. 
Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus. [JOURNAL ARTICLE]
Clin Microbiol Infect 2009 Oct 22.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19843483/full_citation/Clinical_outcomes_of_patients_receiving_daptomycin_for_the_treatment_of_Staphylococcus_aureus_infections_and_assessment_of_clinical_factors_for_daptomycin_failure:_A_retrospective_cohort_study_utilizing_the_Cubicin_R__Outcomes_Registry_and_Experience_Sakoulas G, Brown J, Lamp KC, et al. 
Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: A retrospective cohort study utilizing the Cubicin(R) Outcomes Registry and Experience. [Journal Article]
Clin Ther 2009 Sep; 31(9):1936-45.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19841030/full_citation/Comment_on:_Developments_in_outpatient_parenteral_antimicrobial_therapy__OPAT__for_Gram_positive_infections_in_Europe_and_the_potential_impact_of_daptomycin_Adriaenssens N, Goossens H, Coenen S 
Comment on: Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Oct 19.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19833635/full_citation/In_vitro_activity_of_nemonoxacin__TG_873870__a_novel_non_fluorinated_quinolone_against_clinical_isolates_of_Staphylococcus_aureus_enterococci_and_Streptococcus_pneumoniae_with_various_resistance_phenotypes_in_Taiwan_Chen YH, Liu CY, Lu JJ, et al. 
In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Oct 14.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19825818/full_citation/Effects_of_daptomycin_in_combination_with_other_antimicrobial_agents:_a_review_of_in_vitro_and_animal_model_studies_Steenbergen JN, Mohr JF, Thorne GM 
Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies. [JOURNAL ARTICLE]
J Antimicrob Chemother 2009 Oct 12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles